@article{87f1f46a5d2f4eb0b2b831f9014bb31d,
title = "Risk of venous thromboembolism in women with endometriosis",
keywords = "Endometriosis, Hormones, Risk, Thrombosis, Women",
author = "Wiegers, \{H. M. G.\} and Scheres, \{L. J. J.\} and L. Tahir and Hutten, \{B. A.\} and S. Middeldorp and V. Mijatovic",
note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: HW and LT have nothing to declare. BAH reports receiving a research grant from Silence Therapeutics outside the scope of this work. SM reports grants and personal fees from Bayer, BMS Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Portola, all during the conduct of the study; personal fees form Abbvie, personal fees from Sanofi, all outside the scope of the submitted work. LS received funding for the printing of his doctoral thesis (2019) from the Dutch Heart Foundation, Dutch Federation of Coagulation Clinics, Stichting tot Steun Promovendi Vasculaire Geneeskunde, Bayer, Daiichi Sankyo, LEO Pharma, and Pfizer, outside the scope of this work. VM reports receiving research grants from Ferring, Merck and Guerbet outside the scope of this work.",
year = "2022",
month = sep,
day = "1",
doi = "10.1016/j.thromres.2022.07.014",
language = "English",
volume = "217",
pages = "104--106",
journal = "Thrombosis research",
issn = "0049-3848",
publisher = "Elsevier Limited",
}